IMU

0.00%

4.8¢ imugene limited

Imugene Price Target Raised 47% to A$0.25/Share by Bell Potter, page-40

First 40 Last

Share
Profile

Follow
Wedgeman7

2,011 Posts.

615

08/05/21

10:29

Post #: 53034782
Share

Originally posted by Taureanbull: ↑

Let’s just get out of the weeds , endlessly focussing on pip trading. This distorts perspective with regard to our in our investment. Let’s take a helicopter view of this amazing story.

We have all heard the saying “ You don’t have to be smart to be successful. You can be the dumbest person in the room , so long as your surrounded by smart people”

Professor Weiderman who is the genius behind B Cell Mimotopes that not only treat cancer without side effects, but also circumvent very valuable patent estates held by others, hooked up with Alex Hoos , the godfather of Immunotherapy Drugs.

Alex Hoos head of cancer at GSK, hooks up with Paul Hopper, serial Aussie Biotech promoter, whose done it all. A really great Chairman.

Hopper then poached the highly regarded and experienced Leslie Chong , who has over 300 cancer trials under her belt away from Genentech. Chong packs her bags and says goodbye to friend , family, and co-workers and heads of to run a $3m unheard of startup in Australia. Leaving her already successful career to cure cancer.

Hopper and aching rope in Prof Pravin Kowanyama from Ohio State University who has been quietly beavering away on B Cell technology in the back room of OSU. Another genius joins the IMU team.

The Professor Yuman Fong decides that he should be hooking up with Hopper. Chong gets Hopper in a choke hold and won’t let go until he agrees to hand over Fong and CF33. Another genius is now on board.

This really is a group of highly dedicated intelligent people who are driven by the desire to bring great cancer treatments to the world.

Along the way they also attracted in a lot of not so bright people for this adventure. I’m one of those. Just smart enough to know I’m the dumbest person in the room. But after buying many millions of shares and options btn .005 and .033, I realise this is my biggest ever shot to great wealth whilst helping millions of people along the way.

I am so happy and proud to be part of this unfolding story. I won’t get another opportunity to be in a room with so many brilliant dedicated people ever again.

So I won’t be distracted by by the SP moving down a few pips. Unbelievable and others regularly post comparative valuations from IMU’s peers. This causes me to continually upgrade my valuation model on IMU. AU$1bn does not come within a country mile of where this is going.

My advice is to keep your eye on the big picture here. Trust your management team. The science has been largely validated. Even the animal studies of CF33 are very relevant. CF33 and s fifth generation Oncovirus, it’s nothing new. New technology fails. Whereas fifth generation technology comes with a very big body knowledge and understanding.

Relax and enjoy the ride.

Expand

I'm loving your posts. Keep it going please. Just one gem for you to consider and for all the day trade haters...of which I am not one.

In order to crack the ASX 200 we need 6 months of a certain market cap but more importantly we need liquidity. If like Taureanbull and myself and others are all holders then who provides the liquidity? Traders are welcomed by me for that reason and one other slightly more important reason. Traders need and thrive in highly volatile markets. Volatility is their nectar. IMU price surges and retreats brings in the traders which gives us liquidity and a ticket to the ASX200. So I think we can all stop bagging the pip traders. We need them now more than ever.

IMU Price at posting: 26.0¢ Sentiment: Buy Disclosure: Held
27 Upvote

2 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BUX

Buxton projects new graphite province discovery at WA Narryer play

There are more pages in this discussion • 171 more messages in this thread...

First 40 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 4.8¢		Change 0.000(0.00%)		Mkt cap ! $356.9M

Open	High	Low	Value	Volume
4.9¢	4.9¢	4.8¢	$328.5K	6.792M

Buyers (Bids)

No.	Vol.	Price($)
45	5443565	4.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.9¢	2171910	5

View Market Depth

No.	Vol.	Price($)
45	5443565	0.048
43	4562182	0.047
49	3188200	0.046
61	6392230	0.045
12	2001364	0.044

Price($)	Vol.	No.
0.049	2171910	5
0.050	4756889	17
0.051	6179811	13
0.052	2579418	10
0.053	1158504	8

Last trade - 16.10pm 04/10/2024 (20 minute delay)

IMU (ASX) Chart

Imugene Price Target Raised 47% to A$0.25/Share by Bell Potter, page-40

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Imugene Price Target Raised 47% to A$0.25/Share by Bell Potter, page-40

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News